Le Lézard
Classified in: Health
Subject: PDT

Top Luxury Day Spa Burke Williams Announces 2024 Plans, Massage Industry Trends


LOS ANGELES, April 24, 2024 /PRNewswire/ -- For nearly 40 years Burke Williams has been an innovator and leader in the luxury day spa industry, and in 2024 the company is continuing to deliver relaxing, rejuvenating experiences for guests that truly transform their day.

Burke Williams' focus is on providing the most luxurious, highest-quality facial, massage and spa services while also exploring the evolution of the massage industry, encompassing new massage techniques and emphasizing the necessity for wellness, which provides a temporary escape from reality centered around you.

In particular, the trend to focus on self-care and the importance of escaping everyday life has been on the rise globally for many years, and Burke Williams is happy to be part of the movement knowing that valued guests leave the company's day spas feeling transformed and that's truly why the company exists.  

Additionally, over the years, Burke Williams has seen increasing demand for the company's proprietary skin care products (H2V by Burke Williams) used throughout their spas. And soon groundbreaking news will emerge about the product line.

Burke Williams also launched their Mother's Day gift card packages which are available on their website now for a limited time: https://www.burkewilliams.com/giftcards

About Burke Williams:
For almost 40 years Burke Williams has been recognized as an innovator and leader in the spa industry and the company has built not only a loyal following but also a team that works together to provide the best guest experiences possible. Today, with 11 locations across California, Burke Williams is a sanctuary, a place for wellness and beauty, inspiration and optimism.

Contact:
Diane Hibbard
Chief Treatment Officer
[email protected]

SOURCE Burke Williams


These press releases may also interest you

at 02:11
Calliditas Therapeutics AB ("Calliditas") today announced data from the proof-of-concept Phase 2 trial evaluating setanaxib, its lead NOX enzyme inhibitor, in combination with pembrolizumab, in patients with squamous cell carcinoma of the head and...

at 00:01
The Novo Nordisk Foundation, Wellcome, and the Bill & Melinda Gates Foundation announced a new partnership to support critical scientific research and development (R&D) for global health. The partnership is focused on supporting science and...

5 mai 2024
The Halal Economy Leadership Forum 2024 (HELF 2024) held recently in Riyadh, Saudi Arabia, set the stage for a momentous gathering of industry leaders, policymakers, and experts to advance discussions on the Halal Economy?a vital cornerstone of...

5 mai 2024
Johnson & Johnson announced today updated results from an open-label, multicenter, multi-cohort Phase 1 study of the safety and efficacy of TAR-210, an intravesical targeted releasing system designed to provide sustained, local release of erdafitinib...

5 mai 2024
UroGen Pharma Ltd. , a biotech company dedicated to developing and commercializing novel solutions that treat urothelial and specialty cancers, today highlights the results of a sub-analysis from the first and largest real-world patient cohort review...

5 mai 2024
The Aesthetic Foundation, formerly known as the Aesthetic Surgery Education and Research Foundation (ASERF), proudly announces the election of Dr. Onelio Garcia Jr. "Oni", as its new President. Dr. Garcia's appointment heralds an exciting chapter for...



News published on and distributed by: